Host: |
Rabbit |
Applications: |
WB/IHC/IF |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-KRT16 (190-430) is suitable for use in Western Blot, Immunohistochemistry and Immunofluorescence research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000IHC-P 1:50-1:200IF/ICC 1:50-1:200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
KRT16 |
Gene ID: |
3868 |
Uniprot ID: |
K1C16_HUMAN |
Immunogen Region: |
190-430 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 190-430 of human Cytokeratin 16 (KRT16) (NP_005548.2). |
Immunogen Sequence: |
LQIDNARLAADDFRTKYEHE LALRQTVEADVNGLRRVLDE LTLARTDLEMQIEGLKEELA YLRKNHEEEMLALRGQTGGD VNVEMDAAPGVDLSRILNEM RDQYEQMAEKNRRDAETWFL SKTEELNKEVASNSELVQSS RSEVTELRRVLQGLEIELQS QLSMKASLENSLEETKGRYC MQLSQIQGLIGSVEEQLAQL RCEMEQQSQEYQILLDVKTR LEQEIATYRRLLEGEDAHL |
Tissue Specificity | Expressed in the corneal epithelium (at protein level). |
Function | Epidermis-specific type I keratin that plays a key role in skin. Acts as a regulator of innate immunity in response to skin barrier breach: required for some inflammatory checkpoint for the skin barrier maintenance. |
Protein Name | Keratin - Type I Cytoskeletal 16Cytokeratin-16Ck-16Keratin-16K16 |
Database Links | Reactome: R-HSA-6805567Reactome: R-HSA-6809371 |
Alternative Antibody Names | Anti-Keratin - Type I Cytoskeletal 16 antibodyAnti-Cytokeratin-16 antibodyAnti-Ck-16 antibodyAnti-Keratin-16 antibodyAnti-K16 antibodyAnti-KRT16 antibodyAnti-KRT16A antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance